EU regulation aims to improve research on medicines for children
The use of unlicensed and off-label medicines for children is widespread, yet over 50% of all pharmaceutical products have no scientific data for young people. With its Regulation on Medicinal Products for Paediatric Use the EU aims to promote the development of more medicines specifically for children.